The Clinical Outcomes of Preclinical and Clinical Obesity Across Multiple Cohorts
Obesity · 2026
DOI: 10.1002/oby.70260 ↗Kurz gefasst
Fachartikel in der Zeitschrift Obesity, 2026. Verfasst von Sitong Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, Peking University People's Hospital; Beijing Key Laboratory of Innovative Drug and Device Translation in …. Hauptthemen laut MEDLINE: Obesity, Cardiovascular Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Special Funds of the National Natural Science Foundation of China, Beijing Nova Cross Program of Science and Technology, Peking University People's Hospital Research and Development Funds.
Abstract (Originalsprache)
Objective
The Lancet Diabetes & Endocrinology Commission proposed a new definition for clinical obesity. However, its prognostic value remains unclear.
Methods
Clinical obesity was defined using the Commission's criteria in the China Health and Retirement Longitudinal Study (CHARLS), the English Longitudinal Study of Aging (ELSA), and the National Health and Nutrition Examination Survey (NHANES). Prevalence estimation was conducted across four categories based on obesity and organ dysfunction status. Cox proportional hazards models were used to assess associations with clinical outcomes.
Results
The prevalence of clinical obesity was 2.50% (CHARLS), 6.18% (ELSA), and 9.08% (NHANES), respectively. Overall, older adults and men had lower prevalence, while older men in NHANES showed higher prevalence. Compared with non‐obesity without dysfunctions, clinical obesity and non‐obesity with dysfunctions showed higher risks of cardiovascular outcomes. Compared with preclinical obesity, clinical obesity elevated cardiovascular risk in CHARLS (HR = 2.49, 95% CI: 1.32–4.70) and ELSA (HR = 1.80, 95% CI: 1.02–3.17) and increased all‐cause (HR = 1.88, 95% CI: 1.23–2.87) and cardiovascular (HR = 3.11, 95% CI: 1.49–6.50) mortality risk in NHANES.
Conclusions
The prevalence of clinical obesity varied by age, sex, and country. Overall, the prevalence was lower among older adults and men. Clinical obesity was associated with increased cardiovascular event risk across cohorts and increased all‐cause mortality risk in NHANES, highlighting its value for risk stratification.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Endocrinology and Metabolism, Peking University People's Hospital; Beijing Key Laboratory of Innovative Drug and Device Translation in Endocrine and Metabolic Diseases, Beijing, China.
- Peking University Diabetes Center, Peking University Health Science Center, Beijing, China.
ORCID-Profile: Xueyao Han, Linong Ji
Förderung
- Special Funds of the National Natural Science Foundation of China
- Beijing Nova Cross Program of Science and Technology
- Peking University People's Hospital Research and Development Funds
- 2024 National Clinical Key Specialty Construction Program of China
Zitieren
APA
Li, S., Huang, Q., Liu, Y., Wang, S., Luo, Y., Han, X., Ji, L., & Zou, X. (2026). The Clinical Outcomes of Preclinical and Clinical Obesity Across Multiple Cohorts. Obesity. https://doi.org/10.1002/oby.70260
Vancouver
Li S, Huang Q, Liu Y, Wang S, Luo Y, Han X, et al. The Clinical Outcomes of Preclinical and Clinical Obesity Across Multiple Cohorts. Obesity. 2026. doi:10.1002/oby.70260
BibTeX
@article{Li2026,
author = {Li, Sitong and Huang, Qi and Liu, Yingning and Wang, Song and Luo, Yingying and Han, Xueyao and Ji, Linong and Zou, Xiantong},
title = {The Clinical Outcomes of Preclinical and Clinical Obesity Across Multiple Cohorts},
journal = {Obesity},
year = {2026},
doi = {10.1002/oby.70260}
}
EUVIMED